CPhI Japan

Activities: Recruitment Ingredients Regulatory Digital Pharmaceutical Logistics

Trending Articles

  1. From data to decisions: applying criticality and failure probability in process risk mitigation This article presents an exploration of how structured, data-based methods enhance quality control, optimise specifications and improve process robustness throughout the...
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Stop reviewing good data: review‑by‑exception for chromatography QC Labs spend hours confirming routine chromatograms while real risks hide in plain sight; regulators support a better path if data are captured and surfaced correctly, notes...
  3. SeaBeLife partners with Unither Pharmaceuticals for ophthalmic drug production The new partnership aims to produce clinical and commercial batches of ophthalmic formulation of SeaBeLife’s drug candidate SBL03 to treat degenerative disorders of the...
  4. Manufacturing Chemist Stand Side with GEA and Hovione We discover what exhibitors at CPHI 2025 are showcasing LIVE!
  5. Vileda Professional CE launches revolutionary single-use microfibre mopping system Vileda Professional CE launches revolutionary single-use microfibre mopping system for cleanrooms and controlled environments

Upcoming event

From powder to granules: a deep dive into wet granulation methods

14 January 2026 | Virtual See all

Related Content

Finance

Deprecated Yen attracting renewed international interest in Japanese pharma

Half of all exhibitors at CPHI Japan are international as business links strengthen with Switzerland, Korea, USA and the UK
Manufacturing

Japan produces highest quality APIs, CPhI data says

Several COVID vaccines are approaching commercial launch in Japan, coinciding with an ongoing biosimilars boom
Research & Development

CPhI Japan: Internationalisation reaches new heights

Innovation in the country, driven by structural and and regulatory changes, has promoted both inbound and outbound collaboration
Finance

Pricing system reform and generics trend apparent at CPhI Japan 2018

After recent changes in Japan, which is known to be an innovative drug market, an increase in international generic API companies and suppliers has been reported at next month’s CPhI Japan 2018
Media

CPhI Japan predicts a transformative year for Japanese pharma

A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma, as the market evolves towards growth in generics, biosimilars and increased internationalisation
Pharmaceutical

CPhI Japan to explore changes in generics and OTC

Growing market for generics and liberalisation of OTC medicines driving demand at CPhI Japan
Manufacturing

CPhI Japan

20 - 22 April 2016, Exhibition, Tokyo, Japan
Subscribe now